EUVIMEDEUVIMED entdecken
Leserbrief

Response to correspondence on ‘Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)’

Yuki Imai, Michihito Kono, Tomonori Ishii, Toshihisa Kojima, Shintaro Hirata, Yoshiya Tanaka, Eiichi Tanaka, Koichiro Ohmura, Shunsuke Okamoto, Rumiko Matsumoto, Yuri Sato, Takashi Yamamura und 2 weitere

Annals of the Rheumatic Diseases · 2026-11 · 85 (11) · e133-e134

DOI: 10.1016/j.ard.2026.05.002 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Annals of the Rheumatic Diseases, 2026-11. Verfasst von Yuki Imai und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Department of Haematology and Rheumatology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan.
  • Department of Orthopaedic Surgery, National Hospital Organization Nagoya Medical Centre, Nagoya, Japan.
  • Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.
  • The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan; Department of Molecular Targeted Therapeutics, School of Medicine, University of Occupational and Enviro…

Zitieren

APA

Imai, Y., Kono, M., Ishii, T., Kojima, T., Hirata, S., Tanaka, Y., Tanaka, E., Ohmura, K., Okamoto, S., Matsumoto, R., Sato, Y., Yamamura, T., Takeuchi, T., & Kaneko, Y. (2026). Response to correspondence on ‘Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)’. Annals of the Rheumatic Diseases, 85(11), e133-e134. https://doi.org/10.1016/j.ard.2026.05.002

Vancouver

Imai Y, Kono M, Ishii T, Kojima T, Hirata S, Tanaka Y, et al. Response to correspondence on ‘Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)’. Annals of the Rheumatic Diseases. 2026;85(11):e133-e134. doi:10.1016/j.ard.2026.05.002

BibTeX
@article{Imai2026,
  author = {Imai, Yuki and Kono, Michihito and Ishii, Tomonori and Kojima, Toshihisa and Hirata, Shintaro and Tanaka, Yoshiya and Tanaka, Eiichi and Ohmura, Koichiro and Okamoto, Shunsuke and Matsumoto, Rumiko and Sato, Yuri and Yamamura, Takashi and Takeuchi, Tsutomu and Kaneko, Yuko},
  title = {Response to correspondence on ‘Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)’},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {11},
  pages = {e133--e134},
  doi = {10.1016/j.ard.2026.05.002}
}
Kostenlos starten →